Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM-guided Antifungal Therapy in Hematology Patients
NCT00361517Phase 3Completed
- Sponsor
- Singapore General Hospital
- Start
- Jun 2006
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of amphotericin b deoxycholate in invasive aspergillosis (IA) (2 arms), sponsored by Singapore General Hospital. Primary endpoints: Development of proven or probable invasive fungal infection, Fungal related mortality and 1 more. Started Jun 2006; status: completed.
02
Drugs
amphotericin b deoxycholate
03
Conditions
invasive aspergillosis (IA)
Beyond the preview
Go deeper on NCT00361517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00361517.